To that end, we have shown that clinical RT triggered NFκB in cancer cells leads to the TNFα, IL1α, cMYC and SOD2 dependent paracrine signaling and TNFR1-dependent NFκB mediated NTEs in bystander cells [99]. Here, NFKB1 is linked to cancer.